908 Devices Inc.

NASDAQ:MASS

Medical - Devices

Healthcare
$9.52 +2.51%

+$0.22 today

Market cap
$395.86M
Beta
0.64
P/E (TTM)
-9.0
EPS (TTM)
-$0.97
52W Low $5.03High $9.34

Volume 0.25M

Average 0.27M

MASS Accounts Receivables

Cash effect of the change in amounts owed by customers; growing receivables consume cash.

908 Devices Inc.NASDAQ: MASS

Accounts Receivables · Q1 FY2026 · quarter ended Mar 2026

Accounts receivables declines year over year

Q1 FY2026 accounts receivables of $1.52M fell 67.1% year over year, ahead of the -1376.9% change in trailing-twelve-month accounts receivables. Over 3 fiscal years it compounded at -66.6% a year.

Context

  • Accounts receivables amounted to 0.4% of revenue in FY2025, down 4.5 pp from a year earlier.
  • Accounts receivables increased in 1 of the last 3 fiscal years.

What to watch

Whether quarterly growth of -67.1% holds above the trailing-twelve-month pace of -1376.9%.

Sources:Cash FlowText generated from reported figures; not investment advice.

Latest quarterMar 2026
$1.52M+566.0% QoQ
Last fiscal yearDec 2025
$220K+107.5% YoY
LTMMar 2026
-$2.87M-1376.9% YoY
Accounts Receivables past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter-67.1%——
1 year+107.5%——
3-year CAGR-66.6%——
5-year CAGR——
10-year CAGR——

Accounts Receivables history

USD · from the cash flow

Latest · FY2025
220K USD
Year-over-year change
+107.5%

Accounts Receivables vs competitors

How MASS compares with its peers on the latest reported figures

  • MASS's LTM Mar 2026 accounts receivables of $2.87M is the smallest of the 3 companies compared; the peer median is $48.16M.
  • Its year-over-year change of -1376.9% is the lowest of 3, against a peer median of -41.1%.
  • Accounts receivables amounts to 5.0% of revenue for MASS, versus a peer median of 0.8%.
MASS Competitors Peer median
Accounts Receivables for MASS and competitors
Company Period LTM YoY 3-year CAGR% of revenue
AAgilent Technologies, Inc.LTM Jul 2026$89M -14.4%-22.6%1.2%
QGENQiagen N.V.LTM Jun 2026$7.31M -67.7%—0.3%
MASS908 Devices Inc.LTM Mar 2026$2.87M -1376.9%-66.6%5.0%
Peer median (excluding MASS) $48.16M-41.1%-22.6%0.8%

Competitors are the stored peer set for MASS. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Cash Flow Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Net Income(22.17M)(33.56M)(36.4M)(72.21M)19.49M
Depreciation & Amortization925K1.61M2.38M4.68M3.83M
Deferred Income Tax0(129K)(305K)(283K)0
Stock-Based Compensation2.5M7.21M9.79M11.76M9.85M
Change in Working Capital(12.44M)3.36M(1.57M)(2.54M)(15.3M)
Accounts Receivables(11.28M)5.93M680K(2.93M)220K
Inventory(4.48M)(5.48M)(3.9M)(1.66M)(3.73M)
Accounts Payables2.75M000(5.93M)
Other Working Capital567K2.9M1.65M2.05M(5.86M)
Other Non-Cash Items2.09M584K1.05M28.34M(41.55M)
Operating Cash Flow(29.08M)(20.93M)(25.06M)(30.25M)(23.69M)
Capital Expenditures(737K)(2.05M)(2.05M)(602K)(955K)
Acquisitions (Net)0(13.76M)0(44.78M)(2M)
Purchases of Investments00(48.87M)(55.5M)(64.01M)
Sales of Investments0024.52M54.56M47.8M
Other Investing Activities000069.91M
Investing Cash Flow(737K)(15.81M)(26.4M)(46.32M)50.75M
Debt Repayment(39K)0(15M)00
Common Stock Issued852K1.55M936K1.15M864K
Common Stock Repurchased00000
Dividends Paid00000
Other Financing Activities93.91M(374K)(1.87M)(1.52M)(1.56M)
Financing Cash Flow94.73M1.18M(15.94M)(376K)(697K)
Effect of Forex Changes018K13K(65K)27K
Net Change in Cash64.91M(35.54M)(67.38M)(77.01M)26.39M
Free Cash Flow(29.82M)(22.98M)(27.1M)(30.85M)(24.64M)

908 Devices Inc.

NASDAQ:MASS

Intrinsic Alpha fair value

Locked

Current Price

$9.52

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.